Skip to main content

Day: January 24, 2024

Stock Yards Bancorp Reports Fourth Quarter Earnings of $23.9 Million or $0.82 Per Diluted Share and Record Earnings for the Year

Results Highlighted by Continued Strong Loan Growth LOUISVILLE, Ky., Jan. 24, 2024 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today reported earnings of $23.9 million, or $0.82 per diluted share, for the fourth quarter ended December 31, 2023. This compares to net income of $29.8 million, or $1.01 per diluted share, for the fourth quarter of 2022. For the year ended December 31, 2023, the Company produced record net income of $107.7 million, and diluted earnings per share of $3.67. Strong loan growth across all markets and deposit growth contributed to solid fourth quarter and full year 2023 operating results.       (dollar...

Continue reading

Progressive Reports December 2023 Results

MAYFIELD VILLAGE, OHIO, Jan. 24, 2024 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for December 2023 and the fourth quarter of 2023:    December       Quarter    (millions, except per share amounts and ratios; unaudited)   2023     2023     2022     Change  Net premiums written $ 4,875.9   $ 15,129.8   $ 12,460.2     21 %Net premiums earned $ 5,310.4   $ 15,772.6   $ 12,891.5     22 %Net income $ 901.2   $ 1,987.8   $ 826.4     141 %Per share available to common shareholders $ 1.53   $ 3.37   $ 1.40     141 %Total pretax net realized gains (losses) on securities $ 144.0   $ 303.4   $ (72.8 )   NMCombined ratio   83.4     88.7     93.9     (5.2) pts.Combined ratio – prior year month   93.3                    Average diluted equivalent common shares   587.4     587.5     587.1     0 %NM...

Continue reading

Hepsiburada Announces Changes to its Board of Directors

ISTANBUL, Türkiye, Jan. 24, 2024 (GLOBE NEWSWIRE) — D-MARKET Electronic Services & Trading (d/b/a “Hepsiburada”) (NASDAQ: HEPS), a leading Turkish e-commerce platform (referred to herein as “Hepsiburada” or the “Company”), today announced a change to the composition of its Board of Directors. Effective January 15, 2024, Mr. Murat Emirdağ, a former member of the Company’s Board of Directors, resigned from his position and Mr. Ahmet Toksoy was appointed as a member of the Board of Directors to replace Mr. Murat Emirdağ. The appointment of Mr. Ahmet Toksoy has been registered with the trade registry on January 23, 2024 and it will be submitted for approval at the Company’s next general assembly meeting of shareholders. Mr. Toksoy worked for the Ministry of Finance of the Republic of Türkiye from 1984 to 1989. Later, Mr. Toksoy...

Continue reading

Groupe Casino: Group Casino announces that it has reached agreements with Auchan Retail and Groupement Les Mousquetaires for the sale of Casino hypermarkets and supermarkets

Group Casino announces that it has reached agreements with Auchan Retail and Groupement Les Mousquetaires for the sale of Casino hypermarkets and supermarkets Paris, 24 January 2024 At the end of the exclusive negotiations initiated on December 18, 20231, concerning the sale by the Group Casino of almost all of its hypermarkets and supermarkets2, the Group Casino announces that it has reached agreements with Auchan Retail France* and Groupement Les Mousquetaires**. These agreements provide for the sale of 288 stores (and the service stations attached to the stores), based on an enterprise value of between 1.3 and 1.35 billion euros. The sales to Auchan and Groupement Les Mousquetaires form an indivisible whole. The disposals will take place in the 2nd quarter of 2024, after consultation with the relevant employee representative bodies. The...

Continue reading

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b

– Initiation of CX-2051 Phase 1 clinical study in EpCAM positive tumors including colorectal cancer anticipated in 1H 2024 – – Initiation of CX-801 Phase 1 clinical study in solid tumors including melanoma, renal, and head and neck squamous cell carcinoma also anticipated in 1H 2024 – SOUTH SAN FRANCISCO, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) applications for the conditionally activated Probody® therapeutics CX-2051, an EpCAM-directed ADC, and CX-801, a dually-masked version of interferon-alpha 2b. CX-2051 has been cleared for the initiation of Phase 1 dose...

Continue reading

TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference 

FORT WORTH, Texas, Jan. 24, 2024 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that the Company will present data from the Phase 2 trial of Voriconazole Inhalation Powder (TFF VORI) for the treatment of invasive pulmonary aspergillosis at the upcoming Advances Against Aspergillosis & Mucormycosis (AAAM) Conference, which will be held from January 25-27, 2024, in Milan, Italy. Data being presented at the AAAM Conference were first disclosed by the Company in December 2023. Presentation Details: Presentation Title: “TFF VORI in invasive pulmonary aspergillosis”Presenter: Zamaneh Mikhak, M.D., Chief Medical Officer of TFF...

Continue reading

Twin Disc Announces Details of Fiscal 2024 Second Quarter Earnings Release, Webcast, and Conference Call

MILWAUKEE, Jan. 24, 2024 (GLOBE NEWSWIRE) — Twin Disc, Inc. (NASDAQ: TWIN), today announced that it will release its fiscal 2024 second-quarter results at approximately 8:00 am Eastern on February 7, 2024, and host a webcast and conference call to discuss those results at 9:00 am Eastern. Following their prepared remarks, the Company will host a question-and-answer session with the investment community. The live audio webcast will be available on Twin Disc’s website at https://ir.twindisc.com. To participate in the conference call, please dial (800) 715-9871 approximately ten minutes before the call is scheduled to begin. A replay of the webcast will be available at https://ir.twindisc.com shortly after the call until February 6, 2025. About Twin DiscTwin Disc, Inc. designs, manufactures and sells marine and heavy-duty off-highway...

Continue reading

Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data Announcement

MALVERN, Pa., Jan. 24, 2024 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, has announced a postponement in the Phase III study data release for buntanetap in Parkinson’s Disease. This adjustment is due to ongoing data cleaning efforts to ensure the accuracy and reliability of the study results. “We acknowledge the ongoing anticipation for the Phase III data announcement initially set for the end of January 2024. However, the delivery of the cleaned data is now delayed as we work to provide the most accurate results by ensuring the process is conducted diligently and thoroughly,” said Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis. “During this period, the Company remains blinded to the data, and the...

Continue reading

MLS United, LLC Teams up with Leading REALTOR® Associations in Mississippi to Provide FOREWARN® Services

Mississippi’s Premier Multiple Listing Service, MLS United, LLC, collaborates with Northwest Mississippi REALTORS®, Central Mississippi REALTORS®, and Gulf Coast Association of REALTORS® to enhance agent safety with FOREWARN services. BOCA RATON, Fla., Jan. 24, 2024 (GLOBE NEWSWIRE) — In a significant move to bolster real estate agent safety, FOREWARN, LLC, a subsidiary of red violet company (NASDAQ: RDVT) and a leader in real-time information solutions for real estate professionals, today announced that it has partnered with MLS United, LLC the largest Multiple Listing Service in Mississippi. This collaboration will extend FOREWARN® services to over 6,200+ MLS United customers at no additional cost to individual agents.   Available both online and through a mobile application, FOREWARN® analyzes billions of data points and...

Continue reading

Rodedawg Intl. Ind, Inc. (OTC: RWGI) Acquires and Initiates New California Cannabis Distributor License

Expansion of Distribution Capabilities ContinuesRodedawg International Industries Inc. OTCMARKETS:RWGI LogoRodedawg International Industries Inc. OTCMARKETS:RWGI LogoCOSTA MESA, CA , Jan. 24, 2024 (GLOBE NEWSWIRE) —  Rodedawg International Industries, Inc. (OTC: RWGI) proudly announces the Company, through our wholly owned subsidiary, Parabola Mgmt. LLC, has acquired a new California cannabis distributor license in Coachella, California. Chris Swartz, CEO, states “We are proud to inform our shareholders that since the completion of the acquisition of Parabola Mgmt., LLC we have already started the acquisition and expansion of our cannabis license portfolio. We are especially proud to make this announcement as this is a first quarter 2024 milestone that has happened within the timeline of the Company roadmap. As we had...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.